Zydus receives USFDA approval for skin, heart drugs – DPI Research | Market Research Reports | Market Reports Available

Get In Touch

Zydus receives USFDA approval for skin, heart drugs

Zydus Cadila has received the final approval from the USFDA to market Betamethasone Dipropionate Cream USP, Amlodipine and Atorvastatin Tablets USP.

Zydus Cadila has received the final approval from the USFDA to market Betamethasone Dipropionate Cream USP (US RLD – DIPROLENE® AF), 0.05%. It will be manufactured at the group’s Topical manufacturing facility at Ahmedabad. This medication is a strong corticosteroid and is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Betamethasone reduces the swelling, itching and redness that can occur in these types of conditions.

The group also received a final approval for Amlodipine and Atorvastatin Tablets USP (US RLD – Caduet) in the strengths of 2.5 mg/10 mg, 2.5 mg/20 mg, 2.5 mg/40 mg, 5 mg/10 mg, 5 mg/20 mg, 5 mg/40 mg, 5 mg/80 mg, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg. It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad.

This combination product contains two active ingredients – amlodipine and atorvastatin. Amlodipine reduces blood pressure and the workload on the heart by relaxing the walls of the blood vessels. It is used to lower blood pressure and to treat angina (chest pain). Atorvastatin is used in combination with diet and exercise to treat high cholesterol. It works by blocking an enzyme that is needed to make cholesterol in the body.

Read More @ https://www.biospectrumindia.com/news/43/12487/zydus-receives-usfda-approval-for-skin-heart-drugs.html

Need Custom Research contact @ sales@dpiresearch.com

Related Post
Latest Market Research Reports and Industry Analysis

Find latest and promising market research reports at DPIResearch.com Worldwide Influenza Vaccines Market Size, Share, Analysis, Growth, Trends, and Forecast to 2027 Read more

New report forecasts healthy growth for Human Vaccine Market

DPI Research offers a latest published report on “Global Human Vaccines Market Size, Trends, Opportunities and Growth Potential” delivering key Read more

Gavi authorizes $178M to build Ebola vaccine stockpile,Following Merck approval

After years of collaboration with partners, Merck just last month won the world’s first Ebola vaccine licensure. Now, Gavi, the Read more

Vietnam International and MICE Tourism Market 2020 On-going Demand, Gross Margin, Market Drivers and Forecast 2025

Latest Report Available at DPI Research, “Vietnam International and MICE Tourism, Market” provides pin-point analysis for changing competitive dynamics and Read more

Spread the love
X
Open chat